Ulaanbaatar
President meets representatives of Eiger BioPharmaceuticals. Inc
Politics
Ulaanbaatar/MONTSAME/.
On May 7, President Kh. Battulga received representatives of U.S. based Eiger
BioPharmaceuticals, Inc., including David A. Cory, President and CEO, Ingrid
Choong, Vice President of Investor Relations and Corporate Development, and
John Ferraro, Vice President of Clinical Operations. Eiger BioPharmaceuticals
is implementing the Phase 3 of its lead program which focuses on developing
a treatment for the Hepatitis Delta Virus (HDV) infection.
The company has
been working with Mongolian doctors, especially the Onom Foundation, which is
committed to liver diseases, for the last 11 years. The company representatives
spoke about this cooperation with the President, while exchanging views on the
necessity to introduce the treatment of HDV infection and the situation
surrounding liver diseases.
Mr. Cory noted
the importance of conducting research and creating the conditions for
introduction of the treatment of HDV infection in Mongolia, as well as
preventing the infection, and requested attention on this matter on all levels.
President
Battulga discussed the matter of affordability of the treatment and expressed
his commitment to reducing the high prevalence of liver cirrhosis and cancer
deaths in Mongolia.
source: president.mn
